Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension

Published:2023-07-07 Issue:8 Volume:23 Page:967-973
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Buendia Jefferson Antonio¹²^ORCID,Patino Diana Guerrero¹,Lindarte Erika Fernanda¹

Affiliation:

1. Research Group in Pharmacology and Toxicology”INFARTO”. Department of Pharmacology and Toxicology, University of Antioquia, Medellin, Colombia

2. Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2233698

Reference36 articles.

1. Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry

2. Pulmonary Hypertension in Infants, Children, and Young Adults

3. Children and Adolescents with Pulmonary Arterial Hypertension: Baseline and Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)

4. Survival in Childhood Pulmonary Arterial Hypertension

5. Survival in Patients with Primary Pulmonary Hypertension

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP